Page 189 - PRECONGRESS COURSE 06
P. 189
Supplementation of luteal phase with hCG after GnRH agonist triggering in high risk for OHSS patients
50 45 40 35 30 25 20 15 10
5 0
Severe OHSS
0.0
3.0
1.4
1500 IU Humaidan 1500 IU Radesic & 2013 Tremellen 2011
250 IU Cas llo 2010
3.5
500 IU Cas llo 2010
4.5
1000 IU Cas llo 2010
26.1
1500 IU Seyhan 2013
Supplementation of luteal phase with hCG after GnRH agonist triggering in high risk for OHSS patients
Severe OHSS
4% 95% CI: 0 - 9
Page 185 of 258
PRECONGRESS COURSE 06 I GENEVA, SWITZERLAND – 2 JULY 2017 189
Severe OHSS incidence % 95% CI
